期刊文献+

羟甲戊二酰辅酶A还原酶抑制剂的进展与合理应用 被引量:3

下载PDF
导出
机构地区 北京积水潭医院
出处 《中国全科医学》 CAS CSCD 2002年第10期818-820,共3页 Chinese General Practice
  • 相关文献

参考文献13

  • 1张鉴藩.HMG-CoA还原酶抑制剂的国际市场销售动态及临床评价[J].中国新药杂志,1997,6(4):311-311.
  • 2Koizumi J. Log- Term Efficacy of fluvastatin sodium in patients withfamilial hypercholesterolemia. Am J Cardiol, 1995, 76 (2): 47
  • 3Sprecher DL, Abrams J, Allen JW, et al. Low - dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.Ann Lntern Med, 1994, 120:537-543
  • 4Jacobson TA, Jokubaitis LA, Amorosa LF. Fluvastatin and niacin in hyperchol - esterolemia: A preliminary report on gender differences in efficacy. AmJ Med, 1994, 96 (6): 64-68
  • 5张旭明,伍卫.辛伐他汀的临床应用与展望[J].中国药学杂志,2000,35(1):5-8. 被引量:34
  • 6Knopp RH, Frolich JJ. Efficacy of Pravastatin in patients with PTCA and hyperlipidemia. Circulation, 1999, 74:39
  • 7方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 8Herd JA, Christie M, Ballantryne, et al. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate choleserol elevations. A J Cardiology, 1997, 80 (3): 278-286
  • 9Foley DP, Bonnier H, Jackson G, et al. Prevention of restenosis after coronary balloon angioplasty: rational and design of the fluvastatin angioplasty restenosis (FLARE)trial. AmJ Cardiol, 1994, 73:54
  • 10Bischoff H, Angerbauer R, Bender J, et al. Cerivatatin: pharmacology of a novel synthetic and high active HMG - CoA reductase inhibitor. Atherosclerosis, 1997, 135 (1): 119

二级参考文献8

  • 1中华心血管病杂志编辑委员会血脂异常防治对,中华心血管病杂志,1997年,25卷,169页
  • 2Yaughan C J,Lancet,1996年,348卷,1079页
  • 3李尔曼 邵杰 董志远.吉非贝齐致肌病1例[J].中国新药杂志,1999,8(12):839-839.
  • 4Pogson GW, Kindred LH, Carper BG. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy. Am J Gardio, 1999, 83: 1146.
  • 5Ozdemir O, Boran M, Gokce V, et al. A case with severe rhabdomyolysis and renal failure associated with cerivastatin - gemfibrozil combination therapy-a case report. Angiology, 2000, 51(8): 695 - 7.
  • 6Alexandridis G, Pappas GA, Elisas MS. Rhabdomyolysis due to combination therapy with cerivastatin- gemfibrozil. Am J Med, 2000, 109:261.
  • 7黄震华.新型调脂药物西立伐他汀[J].中国新药与临床杂志,2000,19(5):345-347. 被引量:13
  • 8刘玲,赵水平.贝特类调脂药物的研究及应用进展[J].中国新药与临床杂志,2000,19(5):349-352. 被引量:10

共引文献3098

同被引文献9

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部